Cat: IPD-X11664

Recombinant Canine GFRA1/GDNFR-alpha-1 Protein(HEK293), C-10*His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    GFRA1/GDNFR-alpha-1

  • 简介

    GFRA1 is a co-receptor that recognizes the GDNF ligand family and is involved in the regulation of proliferation, differentiation and migration of neuronal cells. GFRA1 promotes autophagy through the SRC-AMP-activated protein kinase (AMPK) signaling pathway, thereby contributing to the development of cisplatin-induced chemotherapy resistance to osteosarcoma. GFRA1/GDNFR-alpha-1 Protein, Canine (HEK293, His) is the recombinant canine-derived GFRA1/GDNFR-alpha-1 protein, expressed by HEK293 , with C-His labeled tag.

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Biological Activity

    Measured by its binding ability in a functional ELISA. Immobilized Recombinant Canine GDNF at 1 μg/mL binds Recombinant Canine GFR alpha-1/GDNF R alpha-1. The kD is 4.078 nM. Measured by its binding ability in a functional ELISA. Immobilized Recombinant Canine GDNF at 1 μg/mL binds Recombinant Canine GFR alpha ‑1/GDNF R alpha ‑1. The kD is 4.078nM.

  • Alternative Names

    GDNF family receptor alpha-1; GFR-alpha-1; GDNFRA; TRNR1

  • Species

    Canine

  • Source

    HEK293

  • Tag

    C-10*His

  • Purity

    Greater than 95% as determined by reducing SDS-PAGE.

  • Uniprot

    XP_852087.1

  • Expression Region

    D25-S429

  • AA Sequence

    DRLDCVKASDQCLKEQSCSTKYRTLRQCVAGKETNFSLTSGLEAKDECRSAMEALKQKSLYNCRCKRGMKKEKNCLRIYWSMYQSLQGNDLLEDSPYEPVNSRLSDIFRVVPFLPDVLQQVEHIPKGNNCLDAAKACNLDDTCKKYRSAYITPCTTSMSNEVCNRRKCHKALRQFFDKVPAKHSYGMLFCSCRDIACTERRRQTIVPVCSYEEREKPNCLNLQDSCKTNYICRSRLADFFTNCQPESRSASSCLKENYADCLLAYSGLIGTVMTPNYIDSSSLSVAPWCDCSNSGNDLEECLKFLNFFKDNTCLKNAIQAFGNGSDVTVWQPALPVQTTTATTTTAFRAKNKPLGPAGSENEIPTHVLPPCANLQAQKLKSNMSGSTHLCLSDRDYEKNGLSGPS

  • Protein Length

    Partial

  • Molecular Weight

    53-60 kDa

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

GFRA1 (GDNF Family Receptor Alpha 1) is a pivotal receptor involved in the signaling pathway of glial cell-derived neurotrophic factor (GDNF), which plays a crucial role in the survival and differentiation of various neuronal populations. The GFRA1 protein is known to mediate the actions of GDNF, influencing neuronal growth and maintenance, as well as playing significant roles in kidney development and spermatogenesis. Given its importance in neurobiology and potential implications in neurodegenerative diseases, understanding GFRA1's structure and function is essential for developing therapeutic interventions. The recombinant GFRA1 protein has been produced to facilitate detailed studies on its biochemical properties, receptor-ligand interactions, and signaling mechanisms. Through structural analyses and functional assays, researchers aim to elucidate the role of GFRA1 in neurogenesis and its therapeutic potential in conditions such as Parkinson's disease and other neurodegenerative disorders. By harnessing recombinant technology, scientists can better explore GFRA1’s interaction with GDNF and other molecular partners, laying the groundwork for potential drug designs that target this signaling axis to promote neuronal survival and regeneration.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US